BJUI Mini Reviews - Interfering with Cell-Survival Signaling as a Treatment Strategy for Prostate Cancer
This article focuses on some of these key effectors of cell survival and treatment resistance that are particularly pertinent for prostate malignancies, and reviews the results of recent trials of new agents that target these proteins.
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2009 UroToday ® All Rights Reserved |
